pharma · Vascular Dementia · Angioimmunoblastic T-cell Lymphoma · NBP
NovaBridge Biosciences
NovaBridge Biosciences patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Rockville, USA HQ
2016 Founded
26 Employees
Public company Type
NBP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Rockville, USA
- Founded
- 2016
- Employees
- 26
- Programs
- 4
- Drugs
- 7
- Patents
- 0
NovaBridge Biosciences patents
0 pharmaceutical patents indexed for NovaBridge Biosciences. 0 expire within 24 months.
NovaBridge Biosciences has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does NovaBridge Biosciences have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do NovaBridge Biosciences patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.